BCM
CERE

Bayesian Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bayesian Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,382
Closed -$1.84M – 1189
2023
Q4 		$1.84M Buy
43,382
+14,500
+50% +$615K 0.2% 140
2023
Q3 		$630K Buy
+28,882
New +$630K 0.07% 317